Co-pay for New Med: 312/month

[jinx]

My guess is a cruise is in the offering.

That sounds about right to me Bri, unfortunately.
With the Plavix patent due to expire in 2012, B-MS has to make their money somewhere, gawd. Good thing they got the patent extended on their fastest growing *cough* product...

NEW YORK, April 6 (Reuters) - Bristol-Myers Squibb Co said on Monday it will sell its Abilify schizophrenia drug more than two years longer than expected, helping to shore up profits after the company's $5.6 billion-a-year Plavix blood clot preventer faces generic competition in mid-2012.


Abilify, with global sales last year of $2.15 billion, is Bristol-Myers' second-biggest product and one of its fastest growing.

"The extension of the U.S. agreement for Abilify will help Bristol-Myers address an important financial need in 2013,"

Originally Posted by Pico

This drug is an anti-psychotic that they are now marketing for other uses.